Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Elemento Lab
Explore this Website
Home
Affiliations
Research
Toggle Research menu options
Big Data Analytics & Machine Learning
Cancer Genomics
Drug Discovery
Epigenomics
Genetics
Mathematical Modeling
Projects
Proteomics
Spatial Computing
Software
Lab Team
Publications
News
Join Us
Weill Cornell Medicine
Care
Discover
Teach
Home
Affiliations
Research
Lab Team
Publications
News
Join Us
Home
Publications
Publications
Found 44 results
Author
Title
Type
Year
Filters:
Author
is
Sboner, Andrea
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
Casiraghi N
,
Orlando F
,
Ciani Y
,
Xiang J
,
Sboner A
,
Elemento O
,
Attard G
,
Beltran H
,
Demichelis F
,
Romanel A
. 2020.
ABEMUS: platform-specific and data-informed detection of somatic SNVs in cfDNA.
.
Bioinformatics. 36(9):2665-2674.
Glynn S
,
Lipkin S
,
Zhang T
,
Sboner A
,
Elemento O
,
van Besien K
,
Beltran H
. 2019.
The application of precision medicine in diagnosing familial Mediterranean fever.
.
Leuk Lymphoma. 60(8):2091-2093.
B
Sailer V
,
Schiffman MH
,
Kossai M
,
Cyrta J
,
Beg S
,
Sullivan B
,
Pua BB
,
Lee KSteve
,
Talenfeld AD
,
Nanus DM
et al.
. 2018.
Bone biopsy protocol for advanced prostate cancer in the era of precision medicine.
.
Cancer. 124(5):1008-1015.
Segal E
,
Zhang F
,
Lin X
,
King G
,
Shalem O
,
Shilo S
,
Allen WE
,
Alquaddoomi F
,
Altae-Tran H
,
Anders S
et al.
. 2020.
Building an international consortium for tracking coronavirus health status.
.
Nat Med. 26(8):1161-1165.
C
Huang L
,
Fernandes H
,
Zia H
,
Tavassoli P
,
Rennert H
,
Pisapia D
,
Imielinski M
,
Sboner A
,
Rubin MA
,
Kluk M
et al.
. 2017.
The cancer precision medicine knowledge base for structured clinical-grade mutations and interpretations.
.
J Am Med Inform Assoc. 24(3):513-519.
Fernandez EM
,
Eng K
,
Beg S
,
Beltran H
,
Faltas BM
,
Mosquera JMiguel
,
Nanus DM
,
Pisapia DJ
,
Rao RA
,
Robinson BD
et al.
. 2019.
Cancer-Specific Thresholds Adjust for Whole Exome Sequencing-based Tumor Mutational Burden Distribution.
.
JCO Precis Oncol. 3
Augello MA
,
Liu D
,
Deonarine LD
,
Robinson BD
,
Huang D
,
Stelloo S
,
Blattner M
,
Doane AS
,
Wong EWP
,
Chen Y
et al.
. 2019.
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis.
.
Cancer Cell. 35(5):817-819.
Augello MA
,
Liu D
,
Deonarine LD
,
Robinson BD
,
Huang D
,
Stelloo S
,
Blattner M
,
Doane AS
,
Wong EWP
,
Chen Y
et al.
. 2019.
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis.
.
Cancer Cell. 35(4):603-617.e8.
Beltran H
,
Romanel A
,
Conteduca V
,
Casiraghi N
,
Sigouros M
,
Franceschini GMarco
,
Orlando F
,
Fedrizzi T
,
Ku S-Y
,
Dann E
et al.
. 2020.
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer.
.
J Clin Invest. 130(4):1653-1668.
Conteduca V
,
Oromendia C
,
Eng KW
,
Bareja R
,
Sigouros M
,
Molina A
,
Faltas BM
,
Sboner A
,
Mosquera JMiguel
,
Elemento O
et al.
. 2019.
Clinical features of neuroendocrine prostate cancer.
.
Eur J Cancer. 121:7-18.
Faltas BM
,
Prandi D
,
Tagawa ST
,
Molina AM
,
Nanus DM
,
Sternberg C
,
Rosenberg J
,
Mosquera JMiguel
,
Robinson B
,
Elemento O
et al.
. 2016.
Clonal evolution of chemotherapy-resistant urothelial carcinoma.
.
Nat Genet. 48(12):1490-1499.
Vosoughi A
,
Zhang T
,
Shohdy KS
,
Vlachostergios PJ
,
Wilkes DC
,
Bhinder B
,
Tagawa ST
,
Nanus DM
,
Molina AM
,
Beltran H
et al.
. 2020.
Common germline-somatic variant interactions in advanced urothelial cancer.
.
Nat Commun. 11(1):6195.
D
Khosravi P
,
Lysandrou M
,
Eljalby M
,
Li Q
,
Kazemi E
,
Zisimopoulos P
,
Sigaras A
,
Brendel M
,
Barnes J
,
Ricketts C
et al.
. 2021.
A Deep Learning Approach to Diagnostic Classification of Prostate Cancer Using Pathology-Radiology Fusion.
.
J Magn Reson Imaging. 54(2):462-471.
Puca L
,
Gavyert K
,
Sailer V
,
Conteduca V
,
Dardenne E
,
Sigouros M
,
Isse K
,
Kearney M
,
Vosoughi A
,
Fernandez L
et al.
. 2019.
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer.
.
Sci Transl Med. 11(484)
Rennert H
,
Eng K
,
Zhang T
,
Tan A
,
Xiang J
,
Romanel A
,
Kim R
,
Tam W
,
Liu Y-C
,
Bhinder B
et al.
. 2016.
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care.
.
NPJ Genom Med. 1
Beltran H
,
Prandi D
,
Mosquera JMiguel
,
Benelli M
,
Puca L
,
Cyrta J
,
Marotz C
,
Giannopoulou E
,
Chakravarthi BVSK
,
Varambally S
et al.
. 2016.
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.
.
Nat Med. 22(3):298-305.
E
Lin P-C
,
Giannopoulou EG
,
Park K
,
Mosquera JMiguel
,
Sboner A
,
Tewari AK
,
Garraway LA
,
Beltran H
,
Rubin MA
,
Elemento O
. 2013.
Epigenomic alterations in localized and advanced prostate cancer.
.
Neoplasia. 15(4):373-83.
F
Pisapia DJ
,
Ohara K
,
Bareja R
,
Wilkes DC
,
Hissong E
,
Croyle JA
,
Kim J-H
,
Saab J
,
MacDonald TY
,
Beg S
et al.
. 2020.
Fusions involving BCOR and CREBBP are rare events in infiltrating glioma.
.
Acta Neuropathol Commun. 8(1):80.
I
Musselman K
,
Glynn S
,
Mosquera JMiguel
,
Elemento O
,
Sboner A
,
Beltran H
,
Holcomb K
. 2019.
Identification of a therapeutic target using molecular sequencing for treatment of recurrent uterine serous adenocarcinoma.
.
Gynecol Oncol Rep. 28:54-57.
Davis M
,
Martini R
,
Newman L
,
Elemento O
,
White J
,
Verma A
,
Datta I
,
Adrianto I
,
Chen Y
,
Gardner K
et al.
. 2020.
Identification of Distinct Heterogenic Subtypes and Molecular Signatures Associated with African Ancestry in Triple Negative Breast Cancer Using Quantified Genetic Ancestry Models in Admixed Race Populations.
.
Cancers (Basel). 12(5)
Romanel A
,
Garritano S
,
Stringa B
,
Blattner M
,
Dalfovo D
,
Chakravarty D
,
Soong D
,
Cotter KA
,
Petris G
,
Dhingra P
et al.
. 2017.
Inherited determinants of early recurrent somatic mutations in prostate cancer.
.
Nat Commun. 8(1):48.
Beg S
,
Bareja R
,
Ohara K
,
Eng KWha
,
Wilkes DC
,
Pisapia DJ
,
Zoughbi WAl
,
Kudman S
,
Zhang W
,
Rao R
et al.
. 2021.
Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology.
.
Transl Oncol. 14(1):100944.
Robinson D
,
Van Allen EM
,
Wu Y-M
,
Schultz N
,
Lonigro RJ
,
Mosquera J-M
,
Montgomery B
,
Taplin M-E
,
Pritchard CC
,
Attard G
et al.
. 2015.
Integrative Clinical Genomics of Advanced Prostate Cancer.
.
Cell. 162(2):454.
Robinson D
,
Van Allen EM
,
Wu Y-M
,
Schultz N
,
Lonigro RJ
,
Mosquera J-M
,
Montgomery B
,
Taplin M-E
,
Pritchard CC
,
Attard G
et al.
. 2015.
Integrative Clinical Genomics of Advanced Prostate Cancer.
.
Cell. 162(2):454.
Sailer V
,
Eng KWa
,
Zhang T
,
Bareja R
,
Pisapia DJ
,
Sigaras A
,
Bhinder B
,
Romanel A
,
Wilkes D
,
Sticca E
et al.
. 2019.
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.
.
JCO Precis Oncol. 3
1
(current)
2
next ›
last »